NCT02367326View on ClinicalTrials.gov

Identification of Scores Associated With a Favorable Clinical Response With Thiopurines in IBD Patients

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

August 31, 2017

Conditions
Inflammatory Bowel Diseases
Interventions
OTHER

data collection

data collection will be carried out by the investigator during a standard hospitalization of the patient

Trial Locations (15)

14033

CHU Caen, Caen

21079

CHU Dijon, Dijon

25030

CHU Jean Minjoz, Besançon

33604

CHU Bordeaux, Pessac

34295

CHU Montpellier, Montpellier

35033

CHU Rennes, Rennes

42055

CHU Saint-Etienne, Saint-Etienne

44093

CHU Nantes - Hôtel-Dieu, Nantes

45000

CHR Orléans, Orléans

51092

CHU Reims, Reims

54511

CHU Nancy, Nancy

59037

CHRU Lilles, Lilles

69310

CH Lyon Sud, Pierre-Bénite

75012

Hôpital Saint-Antoine, Paris

06200

CHU Nice, Nice

Sponsors

Collaborators (1)

Apsen Farmaceutica S.A.
All Listed Sponsors
collaborator

Apsen Farmaceutica S.A.

INDUSTRY

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER